A possibly more precise risk model showed Adempas helped PAH patients at intermediate risk of death arrive at more favorable ...
The dosing regimen for Winrevair is optimal for balancing safety and effectiveness in adults with PAH, according to clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback